Anatomical factors and device integration require modified diagnostic workflows to manage complicated urinary tract ...
Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus for delivery.
Financing co-led by GordonMD Global Investments® LP and M VenturesCompany rebrands from EG 427 to Cyllene Therapeutics Paris, July 07, 2026 ...
Cyllene Therapeutics ("Cyllene"), formerly known as EG 427, today announced the closing of a €33 million Series C financing round co-led by GordonMD Global Investments® LP ("GordonMD") and Merck ...
Cyllene Therapeutics ("Cyllene"), formerly known as EG 427, today announced the closing of a ?33 million Series C financing round co-led by GordonMD Global Investments® LP ("GordonMD") and Merck ...
As a child born with multiple congenital disabilities, Angelea Yoder Presti remembers the looks, the whispers and the feeling ...
Financing co-led by GordonMD Global Investments and Merck Ventures B.V. (an affiliate of Merck KGaA, Darmstadt Germany) with participation from new and existing investors Company Rebrands ...
Joe DiMaggio Children's Hospital made history with its first remote living donor kidney transplant, giving 18-year-old ...
Wellbeing Magazine on MSN
Patient monitoring devices in general practice: A practical guide for GP clinics
Accurate patient monitoring is not an optional extra in general practice. It is a fundamental part of the clinical encounter, ...
We present a middle childhood boy with type 1b diabetes mellitus (defined as insulin-dependent diabetes mellitus without ...
Vertex Pharmaceuticals Incorporated will report its second quarter 2026 financial results on Monday, August 3, 2026, after the financial markets close. The company will host a conference call and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results